{"id":528,"date":"2023-10-10T16:30:05","date_gmt":"2023-10-10T16:30:05","guid":{"rendered":"https:\/\/vigilantbiosciences.com\/?p=528"},"modified":"2023-11-20T16:59:16","modified_gmt":"2023-11-20T16:59:16","slug":"transforming-oral-cancer-care-integrating-vigilant-biosciences-solutions-into-your-practice-for-early-detection-and-improved-patient-outcomes","status":"publish","type":"post","link":"https:\/\/vigilantbiosciences.com\/de\/transformieren-sie-die-behandlung-von-mundkrebs-und-integrieren-sie-losungen-der-vigilant-biosciences-in-ihre-praxis-um-eine-fruhzeitige-erkennung-und-bessere-patientenergebnisse-zu-erzielen\/","title":{"rendered":"Transformation der Mundkrebsversorgung: Integration der Vigilant Biosciences\u00ae-L\u00f6sungen in Ihre Praxis zur Fr\u00fcherkennung und Verbesserung der Patientenergebnisse"},"content":{"rendered":"<p>[et_pb_section fb_built=\u201c1\u2033 _builder_version=\u201c4.16\u2033 lock=\u201coff\u201c global_colors_info=\u201c{}\u201c][et_pb_row _builder_version=\u201c4.16\u2033 background_size=\u201cinitial\u201c background_position=\u201ctop_left\u201c background_repeat=\u201crepeat\u201c global_colors_info=\u201c{ }\u201c][et_pb_column type=\u201c4_4\u2033 _builder_version=\u201c4.16\u2033 custom_padding=\u201c|||\u201c global_colors_info=\u201c{}\u201c custom_padding__hover=\u201c|||\u201c][et_pb_text _builder_version=\u201c4.23.1\u2033 header_2_font_size=\u201c24px\u201c header_2_line_height=\u201c1.4em\u201c background_size=\u201cinitial\u201c background_position=\u201ctop_left\u201c background_repeat=\u201crepeat\u201c custom_padding =\u201c25px||||false|false\u201c global_colors_info=\u201c{}\u201c]Als Pionier bei L\u00f6sungen zur Fr\u00fcherkennung von Mundkrebs ist Vigilant Biosciences\u00ae bestrebt, Klinikern bei der Diagnose von Mundkrebs im Stadium I und II zu helfen, um den Behandlungsbeginn zu beschleunigen und den Patienten zu helfen Ergebnisse. Unser Team nutzt jahrzehntelange klinische Fachkompetenz und F\u00fchrungsqualit\u00e4ten im Gesundheitswesen, um bahnbrechende Technologien zu entwickeln, die die Erkennung von Mundkrebs revolutionieren und letztendlich Leben retten \u201ebackground_size=\u201cinitial\u201c background_position=\u201ctop_left\u201c background_repeat=\u201crepeat\u201c custom_padding=\u201c25px||||false|false\u201c hover_enabled=\u201c0\u2033 global_colors_info=\u201c{}\u201c sticky_enabled=\u201c0\u2033]<\/p>\n<h2>Warum Fr\u00fcherkennung entscheidend ist<\/h2>\n<p>Mundkrebs stellt eine erhebliche Bedrohung f\u00fcr die \u00f6ffentliche Gesundheit dar. Mit mehr als 744.000 F\u00e4llen pro Jahr weltweit<sup>1<\/sup> und eine F\u00fcnf-Jahres-\u00dcberlebensrate von weniger als 50%<sup>2<\/sup>, sind die Ergebnisse bei Mundkrebs au\u00dferordentlich schlecht \u2013 k\u00f6nnten aber durch proaktives Screening und Fr\u00fcherkennung verbessert werden. Wenn orale L\u00e4sionen undiagnostiziert werden und die g\u00e4ngige Praxis des \u201eAbwartens und Beobachtens\u201c praktiziert wird, m\u00fcssen sich Patienten h\u00e4ufig mit der Diagnose Mundkrebs im Sp\u00e4tstadium konfrontiert sehen. Tats\u00e4chlich wird gesch\u00e4tzt, dass mehr als zwei Drittel aller Mundkrebserkrankungen in den Stadien III und IV diagnostiziert werden.<sup>3<\/sup><\/p>\n<p>F\u00fcr die meisten sind zum \u00dcberleben umfangreiche rekonstruktive Operationen, Prothesen, Chemotherapie, Bestrahlung und jahrelange Rehabilitationstherapie erforderlich, um die k\u00f6rperliche Funktionsf\u00e4higkeit wiederherzustellen und die Mundgesundheit zu erhalten. Wenn Patienten im Stadium I und II diagnostiziert werden, haben sie nicht nur eine h\u00f6here \u00dcberlebenschance, die auf 80-90% gesch\u00e4tzt wird, sondern k\u00f6nnen auch gr\u00f6\u00dfere chirurgische Eingriffe, lange Genesungszeiten und die schnell steigenden Kosten der Krebsbehandlung vermeiden. [\/et_pb_text][et_pb_text admin_label=\u201cWo traditionelle Screening-Methoden zu kurz kommen\u201c _builder_version=\u201c4.23.1\u2033 header_2_font_size=\u201c24px\u201c header_2_line_height=\u201c1.4em\u201c background_size=\u201cinitial\u201c background_position=\u201ctop_left\u201c background_repeat=\u201crepeat\u201c custom_padding =\u201c25px||||false|false\u201c global_colors_info=\u201c{}\u201c]<\/p>\n<h2>Wo traditionelle Screening-Methoden nicht ausreichen<\/h2>\n<p>In der Vergangenheit spielten Standardmethoden zur Fr\u00fcherkennung von Mundkrebs wie visuelle Untersuchungen und Palpation eine zentrale Rolle bei der Identifizierung verd\u00e4chtiger L\u00e4sionen. Allerdings sind diese Methoden oft nicht in der Lage, vorl\u00e4ufige b\u00f6sartige Erkrankungen zu erkennen, selbst wenn sie Anzeichen und Symptome im Fr\u00fchstadium aufweisen. Bei visuellen Untersuchungen k\u00f6nnen fr\u00fche, subtile Ver\u00e4nderungen leicht \u00fcbersehen werden, w\u00e4hrend bei der Palpation Anomalien unter der Schleimhautoberfl\u00e4che in der Regel nicht erkannt werden k\u00f6nnen. Die inh\u00e4rente Subjektivit\u00e4t der Erkennungsmethoden f\u00fchrt zu einer verz\u00f6gerten Diagnose und wesentlich schlechteren Ergebnissen.[\/et_pb_text][et_pb_text admin_label=\u201cEinf\u00fchrung in das BeVigilant\u2122 OraFusion\u2122 System\u201c _builder_version=\u201c4.23.1\u2033 header_2_font_size=\u201c24px\u201c header_2_line_height=\u201c1.4em\u201c background_size=\u201cinitial\u201c background_position=\u201ctop_left\u201c background_repeat=\u201crepeat\u201c custom_padding=\u201c25px||||false|false\u201c global_colors_info=\u201c{}\u201c]<\/p>\n<h2>Wir stellen vor: das BeVigilant\u2122 OraFusion\u2122 System<\/h2>\n<p>Nach Jahren der Tests und Entwicklung hat Vigilant Biosciences\u00ae mit dem BeVigilant\u2122 OraFusion\u2122 System einen gro\u00dfen Schritt nach vorne in der Behandlung von Mundkrebs gemacht. Als von der FDA als bahnbrechendes Ger\u00e4t anerkanntes Ger\u00e4t dient das BeVigilant\u2122 OraFusion\u2122 System als pr\u00e4zises und zuverl\u00e4ssiges Instrument zur Risikobewertung am Behandlungsstuhl und versorgt Kliniker mit den entscheidenden Informationen, die sie ben\u00f6tigen, um die Erkennung von Mundkrebs mit beispielloser Genauigkeit und Sicherheit zu beschleunigen.<\/p>\n<p>Das BeVigilant\u2122 OraFusion\u2122 System vereint modernste Technologie und klinische Genauigkeit, um das Gesicht der Mundkrebsvorsorge zu ver\u00e4ndern durch:[\/et_pb_text][et_pb_text admin_label=\u201cEinf\u00fchrung des BeVigilant\u2122 OraFusion\u2122 Systems\u201c _builder_version=\u201c4.23.1\u2033 header_2_font_size= \u201e24px\u201c header_2_line_height=\u201c1.4em\u201c background_size=\u201cinitial\u201c background_position=\u201ctop_left\u201c background_repeat=\u201crepeat\u201c custom_margin=\u201c||||false|false\u201c custom_padding=\u201c5px||||false|true\u201c global_colors_info=\u201c {}\u201c]<\/p>\n<ul>\n<li>Identifizierung von Speichel-Biomarkern. Wenn orale L\u00e4sionen b\u00f6sartig werden, werden bestimmte proteinbasierte Biomarker \u00fcberexprimiert. Vigilant Biosciences\u00ae f\u00fchrte \u00fcber 14.000 Tests durch, um zwei Speichelbiomarker im Fr\u00fchstadium mit komplement\u00e4rer Nachweisgenauigkeit zu isolieren.<\/li>\n<li>Klinische Risikofaktoranalyse. Um eine individuellere Beurteilung zu erm\u00f6glichen, nutzt das BeVigilant\u2122 OraFusion\u2122 System intelligente softwaregesteuerte Analysen, um Alter, Geschlecht, Rasse, Alkoholkonsum und Tabakkonsum jedes Patienten zu bewerten. Diese Ergebnisse werden mit der Identifizierung von Biomarkern gepaart, um eine \u00e4u\u00dferst genaue Risikoanalyse zu erm\u00f6glichen.<\/li>\n<li>Objektive Messungen. Das BeVigilant\u2122 OraFusion\u2122 System quantifiziert die doppelte Analyse von Speichelbiomarkern und klinischen Risikofaktoren, um eine \u00e4u\u00dferst genaue Risikobewertung zu erstellen. Jeder Test liefert ein \u201eniedriges\u201c, \u201em\u00e4\u00dfiges\u201c oder \u201eerh\u00f6htes\u201c Ergebnis mit einer Sensitivit\u00e4t und Spezifit\u00e4t von \u00fcber 90%.<sup>4<\/sup><\/li>\n<li>Einfache Integration und schnelle Ergebnisse. In maximal 15 Minuten k\u00f6nnen \u00c4rzte das Mundkrebsrisiko eines Patienten einsch\u00e4tzen und richtig entscheiden, ob sie einen Spezialisten \u00fcberweisen oder abwarten sollten. Das BeVigilant\u2122 OraFusion\u2122 System l\u00e4sst sich nahtlos in standardm\u00e4\u00dfige klinische Arbeitsabl\u00e4ufe integrieren und macht es so einfacher denn je, die Erkennung am Point-of-Care zu beschleunigen.<\/li>\n<\/ul>\n<p>[\/et_pb_text][et_pb_text admin_label=\u201cWeitere Informationen\u201c _builder_version=\u201c4.23.1\u2033 header_2_font_size=\u201c24px\u201c header_2_line_height=\u201c1.4em\u201c background_size=\u201cinitial\u201c background_position=\u201ctop_left\u201c background_repeat=\u201crepeat\u201c custom_padding=\u201c|| ||false|false\u201c global_colors_info=\u201c{}\u201c]<\/p>\n<p><a href=\"https:\/\/vigilantbiosciences.com\/de\/\">Erfahren Sie mehr dar\u00fcber, wie das BeVigilant\u2122 OraFusion\u2122 System dringend ben\u00f6tigte Daten liefert, um \u00c4rzten an vorderster Front dabei zu helfen, die Erkennung zu transformieren, Ergebnisse zu verbessern und Leben zu retten.<\/a><\/p>\n<p>[\/et_pb_text][et_pb_text admin_label=\u201cQuellen\u201c _builder_version=\u201c4.22.2\u201c text_font_size=\u201c14px\u201c header_2_font_size=\u201c24px\u201c header_2_line_height=\u201c1.4em\u201c background_size=\u201cinitial\u201c background_position=\u201ctop_left\u201c background_repeat=\u201crepeat\u201c global_colors_info =\u201c{}\u201c]<strong>Quellen<\/strong><\/p>\n<p>1. Internationaler Weltkrebsforschungsfonds. (2022, 14. April). Statistiken zu Mund- und Mundkrebs. WCRF International. <a href=\"https:\/\/www.wcrf.org\/cancer-trends\/mouth-and-oral-cancer-statistics\/\" target=\"_blank\" rel=\"noopener\">https:\/\/www.wcrf.org\/cancer-trends\/mouth-and-oral-cancer-statistics\/<\/a><br \/>\n2. Gonz\u00e1lez-Moles, M.\u00c1., Aguilar-Ruiz, M., &amp; Ramos-Garc\u00eda, P. (2022). Herausforderungen bei der Fr\u00fchdiagnose von Mundkrebs, Evidenzl\u00fccken und Verbesserungsstrategien: Eine umfassende \u00dcberpr\u00fcfung systematischer \u00dcberpr\u00fcfungen. Krebserkrankungen 14(19), 4967.<br \/>\n3. Mund- und Rachenkrebs \u2013 Statistiken. Krebs.Net. (2023, 9. Mai). <a href=\"https:\/\/www.cancer.net\/cancer-types\/oral-and-oropharyngeal-cancer\/statistics\" target=\"_blank\" rel=\"noopener\">https:\/\/www.cancer.net\/cancer-types\/oral-and-oropharyngeal-cancer\/statistics<\/a><br \/>\n4. Landis, G., Mardy, Z., Donovan, M., Nebrigic, D. (2022). Neuartiges bahnbrechendes OraFusion\u2122-System zur Risikobewertung verd\u00e4chtiger oraler L\u00e4sionen in der Zahnarztpraxis [White Paper]. Vigilant Biosciences\u00ae.[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>","protected":false},"excerpt":{"rendered":"<p>Als Pionier bei L\u00f6sungen zur Fr\u00fcherkennung von Mundkrebs ist Vigilant Biosciences\u00ae bestrebt, \u00c4rzte bei der Diagnose von Mundkrebs im Stadium I und II zu unterst\u00fctzen, um den Behandlungsbeginn zu beschleunigen und die Patientenergebnisse zu verbessern. Unser Team nutzt jahrzehntelange spezialisierte klinische Expertise und F\u00fchrungsqualit\u00e4ten im Gesundheitswesen, um bahnbrechende Technologien zu entwickeln, die die Erkennung von Mundkrebs revolutionieren und letztendlich Leben retten. Warum [\u2026]<\/p>","protected":false},"author":3,"featured_media":545,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-528","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Transforming Oral Cancer Care: Integrating Vigilant Biosciences\u00ae Solutions into Your Practice for Early Detection and Improved Patient Outcomes - Vigilant Biosciences\u00ae<\/title>\n<meta name=\"description\" content=\"Learn how the BeVigilant\u2122 OraFusion\u2122 System leverages cutting-edge risk assessment technology to help accelerate oral cancer detection and improve outcomes.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/vigilantbiosciences.com\/de\/transformieren-sie-die-behandlung-von-mundkrebs-und-integrieren-sie-losungen-der-vigilant-biosciences-in-ihre-praxis-um-eine-fruhzeitige-erkennung-und-bessere-patientenergebnisse-zu-erzielen\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Transforming Oral Cancer Care: Integrating Vigilant Biosciences\u00ae Solutions into Your Practice for Early Detection and Improved Patient Outcomes - Vigilant Biosciences\u00ae\" \/>\n<meta property=\"og:description\" content=\"Learn how the BeVigilant\u2122 OraFusion\u2122 System leverages cutting-edge risk assessment technology to help accelerate oral cancer detection and improve outcomes.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/vigilantbiosciences.com\/de\/transformieren-sie-die-behandlung-von-mundkrebs-und-integrieren-sie-losungen-der-vigilant-biosciences-in-ihre-praxis-um-eine-fruhzeitige-erkennung-und-bessere-patientenergebnisse-zu-erzielen\/\" \/>\n<meta property=\"og:site_name\" content=\"Vigilant Biosciences\u00ae\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/VigilantBiosciences1\" \/>\n<meta property=\"article:published_time\" content=\"2023-10-10T16:30:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-11-20T16:59:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/vigilantbiosciences.com\/wp-content\/uploads\/dental-exam-2.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"600\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"dex.manley\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Verfasst von\" \/>\n\t<meta name=\"twitter:data1\" content=\"dex.manley\" \/>\n\t<meta name=\"twitter:label2\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/vigilantbiosciences.com\/transforming-oral-cancer-care-integrating-vigilant-biosciences-solutions-into-your-practice-for-early-detection-and-improved-patient-outcomes\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/transforming-oral-cancer-care-integrating-vigilant-biosciences-solutions-into-your-practice-for-early-detection-and-improved-patient-outcomes\/\"},\"author\":{\"name\":\"dex.manley\",\"@id\":\"https:\/\/vigilantbiosciences.com\/#\/schema\/person\/c954f6495481e2c9b650737c0519a357\"},\"headline\":\"Transforming Oral Cancer Care: Integrating Vigilant Biosciences\u00ae Solutions into Your Practice for Early Detection and Improved Patient Outcomes\",\"datePublished\":\"2023-10-10T16:30:05+00:00\",\"dateModified\":\"2023-11-20T16:59:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/transforming-oral-cancer-care-integrating-vigilant-biosciences-solutions-into-your-practice-for-early-detection-and-improved-patient-outcomes\/\"},\"wordCount\":982,\"publisher\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/#organization\"},\"articleSection\":[\"News\"],\"inLanguage\":\"de-DE\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/vigilantbiosciences.com\/transforming-oral-cancer-care-integrating-vigilant-biosciences-solutions-into-your-practice-for-early-detection-and-improved-patient-outcomes\/\",\"url\":\"https:\/\/vigilantbiosciences.com\/transforming-oral-cancer-care-integrating-vigilant-biosciences-solutions-into-your-practice-for-early-detection-and-improved-patient-outcomes\/\",\"name\":\"Transforming Oral Cancer Care: Integrating Vigilant Biosciences\u00ae Solutions into Your Practice for Early Detection and Improved Patient Outcomes - Vigilant Biosciences\u00ae\",\"isPartOf\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/#website\"},\"datePublished\":\"2023-10-10T16:30:05+00:00\",\"dateModified\":\"2023-11-20T16:59:16+00:00\",\"description\":\"Learn how the BeVigilant\u2122 OraFusion\u2122 System leverages cutting-edge risk assessment technology to help accelerate oral cancer detection and improve outcomes.\",\"breadcrumb\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/transforming-oral-cancer-care-integrating-vigilant-biosciences-solutions-into-your-practice-for-early-detection-and-improved-patient-outcomes\/#breadcrumb\"},\"inLanguage\":\"de-DE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/vigilantbiosciences.com\/transforming-oral-cancer-care-integrating-vigilant-biosciences-solutions-into-your-practice-for-early-detection-and-improved-patient-outcomes\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/vigilantbiosciences.com\/transforming-oral-cancer-care-integrating-vigilant-biosciences-solutions-into-your-practice-for-early-detection-and-improved-patient-outcomes\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/vigilantbiosciences.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Transforming Oral Cancer Care: Integrating Vigilant Biosciences\u00ae Solutions into Your Practice for Early Detection and Improved Patient Outcomes\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/vigilantbiosciences.com\/#website\",\"url\":\"https:\/\/vigilantbiosciences.com\/\",\"name\":\"Vigilant Biosciences\u00ae\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/vigilantbiosciences.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"de-DE\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/vigilantbiosciences.com\/#organization\",\"name\":\"Vigilant Biosciences\u00ae\",\"url\":\"https:\/\/vigilantbiosciences.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de-DE\",\"@id\":\"https:\/\/vigilantbiosciences.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/vigilantbiosciences.com\/wp-content\/uploads\/vigilant-logo-horizontal.svg\",\"contentUrl\":\"https:\/\/vigilantbiosciences.com\/wp-content\/uploads\/vigilant-logo-horizontal.svg\",\"width\":\"1024\",\"height\":\"1024\",\"caption\":\"Vigilant Biosciences\u00ae\"},\"image\":{\"@id\":\"https:\/\/vigilantbiosciences.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/VigilantBiosciences1\",\"https:\/\/www.linkedin.com\/company\/vigilant-biosciences\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/vigilantbiosciences.com\/#\/schema\/person\/c954f6495481e2c9b650737c0519a357\",\"name\":\"dex.manley\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de-DE\",\"@id\":\"https:\/\/vigilantbiosciences.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9c9934d51bab705bbbcd551065e23c9b05e2fcd3a8920b2216c542e8fccc02d8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9c9934d51bab705bbbcd551065e23c9b05e2fcd3a8920b2216c542e8fccc02d8?s=96&d=mm&r=g\",\"caption\":\"dex.manley\"},\"url\":\"https:\/\/vigilantbiosciences.com\/de\/author\/dex-manley\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Transforming Oral Cancer Care: Integrating Vigilant Biosciences\u00ae Solutions into Your Practice for Early Detection and Improved Patient Outcomes - Vigilant Biosciences\u00ae","description":"Learn how the BeVigilant\u2122 OraFusion\u2122 System leverages cutting-edge risk assessment technology to help accelerate oral cancer detection and improve outcomes.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/vigilantbiosciences.com\/de\/transformieren-sie-die-behandlung-von-mundkrebs-und-integrieren-sie-losungen-der-vigilant-biosciences-in-ihre-praxis-um-eine-fruhzeitige-erkennung-und-bessere-patientenergebnisse-zu-erzielen\/","og_locale":"de_DE","og_type":"article","og_title":"Transforming Oral Cancer Care: Integrating Vigilant Biosciences\u00ae Solutions into Your Practice for Early Detection and Improved Patient Outcomes - Vigilant Biosciences\u00ae","og_description":"Learn how the BeVigilant\u2122 OraFusion\u2122 System leverages cutting-edge risk assessment technology to help accelerate oral cancer detection and improve outcomes.","og_url":"https:\/\/vigilantbiosciences.com\/de\/transformieren-sie-die-behandlung-von-mundkrebs-und-integrieren-sie-losungen-der-vigilant-biosciences-in-ihre-praxis-um-eine-fruhzeitige-erkennung-und-bessere-patientenergebnisse-zu-erzielen\/","og_site_name":"Vigilant Biosciences\u00ae","article_publisher":"https:\/\/www.facebook.com\/VigilantBiosciences1","article_published_time":"2023-10-10T16:30:05+00:00","article_modified_time":"2023-11-20T16:59:16+00:00","og_image":[{"width":1200,"height":600,"url":"https:\/\/vigilantbiosciences.com\/wp-content\/uploads\/dental-exam-2.jpg","type":"image\/jpeg"}],"author":"dex.manley","twitter_card":"summary_large_image","twitter_misc":{"Verfasst von":"dex.manley","Gesch\u00e4tzte Lesezeit":"4 Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/vigilantbiosciences.com\/transforming-oral-cancer-care-integrating-vigilant-biosciences-solutions-into-your-practice-for-early-detection-and-improved-patient-outcomes\/#article","isPartOf":{"@id":"https:\/\/vigilantbiosciences.com\/transforming-oral-cancer-care-integrating-vigilant-biosciences-solutions-into-your-practice-for-early-detection-and-improved-patient-outcomes\/"},"author":{"name":"dex.manley","@id":"https:\/\/vigilantbiosciences.com\/#\/schema\/person\/c954f6495481e2c9b650737c0519a357"},"headline":"Transforming Oral Cancer Care: Integrating Vigilant Biosciences\u00ae Solutions into Your Practice for Early Detection and Improved Patient Outcomes","datePublished":"2023-10-10T16:30:05+00:00","dateModified":"2023-11-20T16:59:16+00:00","mainEntityOfPage":{"@id":"https:\/\/vigilantbiosciences.com\/transforming-oral-cancer-care-integrating-vigilant-biosciences-solutions-into-your-practice-for-early-detection-and-improved-patient-outcomes\/"},"wordCount":982,"publisher":{"@id":"https:\/\/vigilantbiosciences.com\/#organization"},"articleSection":["News"],"inLanguage":"de-DE"},{"@type":"WebPage","@id":"https:\/\/vigilantbiosciences.com\/transforming-oral-cancer-care-integrating-vigilant-biosciences-solutions-into-your-practice-for-early-detection-and-improved-patient-outcomes\/","url":"https:\/\/vigilantbiosciences.com\/transforming-oral-cancer-care-integrating-vigilant-biosciences-solutions-into-your-practice-for-early-detection-and-improved-patient-outcomes\/","name":"Transforming Oral Cancer Care: Integrating Vigilant Biosciences\u00ae Solutions into Your Practice for Early Detection and Improved Patient Outcomes - Vigilant Biosciences\u00ae","isPartOf":{"@id":"https:\/\/vigilantbiosciences.com\/#website"},"datePublished":"2023-10-10T16:30:05+00:00","dateModified":"2023-11-20T16:59:16+00:00","description":"Learn how the BeVigilant\u2122 OraFusion\u2122 System leverages cutting-edge risk assessment technology to help accelerate oral cancer detection and improve outcomes.","breadcrumb":{"@id":"https:\/\/vigilantbiosciences.com\/transforming-oral-cancer-care-integrating-vigilant-biosciences-solutions-into-your-practice-for-early-detection-and-improved-patient-outcomes\/#breadcrumb"},"inLanguage":"de-DE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/vigilantbiosciences.com\/transforming-oral-cancer-care-integrating-vigilant-biosciences-solutions-into-your-practice-for-early-detection-and-improved-patient-outcomes\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/vigilantbiosciences.com\/transforming-oral-cancer-care-integrating-vigilant-biosciences-solutions-into-your-practice-for-early-detection-and-improved-patient-outcomes\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/vigilantbiosciences.com\/"},{"@type":"ListItem","position":2,"name":"Transforming Oral Cancer Care: Integrating Vigilant Biosciences\u00ae Solutions into Your Practice for Early Detection and Improved Patient Outcomes"}]},{"@type":"WebSite","@id":"https:\/\/vigilantbiosciences.com\/#website","url":"https:\/\/vigilantbiosciences.com\/","name":"Vigilant Biosciences\u00ae","description":"","publisher":{"@id":"https:\/\/vigilantbiosciences.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/vigilantbiosciences.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"de-DE"},{"@type":"Organization","@id":"https:\/\/vigilantbiosciences.com\/#organization","name":"Vigilant Biosciences\u00ae","url":"https:\/\/vigilantbiosciences.com\/","logo":{"@type":"ImageObject","inLanguage":"de-DE","@id":"https:\/\/vigilantbiosciences.com\/#\/schema\/logo\/image\/","url":"https:\/\/vigilantbiosciences.com\/wp-content\/uploads\/vigilant-logo-horizontal.svg","contentUrl":"https:\/\/vigilantbiosciences.com\/wp-content\/uploads\/vigilant-logo-horizontal.svg","width":"1024","height":"1024","caption":"Vigilant Biosciences\u00ae"},"image":{"@id":"https:\/\/vigilantbiosciences.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/VigilantBiosciences1","https:\/\/www.linkedin.com\/company\/vigilant-biosciences\/"]},{"@type":"Person","@id":"https:\/\/vigilantbiosciences.com\/#\/schema\/person\/c954f6495481e2c9b650737c0519a357","name":"dex.manley","image":{"@type":"ImageObject","inLanguage":"de-DE","@id":"https:\/\/vigilantbiosciences.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/9c9934d51bab705bbbcd551065e23c9b05e2fcd3a8920b2216c542e8fccc02d8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9c9934d51bab705bbbcd551065e23c9b05e2fcd3a8920b2216c542e8fccc02d8?s=96&d=mm&r=g","caption":"dex.manley"},"url":"https:\/\/vigilantbiosciences.com\/de\/author\/dex-manley\/"}]}},"_links":{"self":[{"href":"https:\/\/vigilantbiosciences.com\/de\/wp-json\/wp\/v2\/posts\/528","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vigilantbiosciences.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vigilantbiosciences.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vigilantbiosciences.com\/de\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/vigilantbiosciences.com\/de\/wp-json\/wp\/v2\/comments?post=528"}],"version-history":[{"count":0,"href":"https:\/\/vigilantbiosciences.com\/de\/wp-json\/wp\/v2\/posts\/528\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/vigilantbiosciences.com\/de\/wp-json\/wp\/v2\/media\/545"}],"wp:attachment":[{"href":"https:\/\/vigilantbiosciences.com\/de\/wp-json\/wp\/v2\/media?parent=528"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vigilantbiosciences.com\/de\/wp-json\/wp\/v2\/categories?post=528"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vigilantbiosciences.com\/de\/wp-json\/wp\/v2\/tags?post=528"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}